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Abstract:  High  intake  of  dietary  fiber  is  claimed  to  protect  against  development  of 
colorectal cancer. Barley is a rich source of dietary fiber, and possible immunomodulatory 
effects of barley polysaccharides might explain a potential protective effect. Dietary fiber 
was isolated by extraction and enzyme treatment. A mixed-linked β-glucan (WSM-TPX, 
96.5% β-glucan, Mw 886 kDa), an arabinoxylan (WUM-BS-LA, 96.4% arabinoxylan, Mw 
156 kDa), a mixed-linked β-glucan rich fraction containing 10% arabinoxylan (WSM-TP) 
and  an  arabinoxylan  rich  fraction  containing  30%  mixed-linked  β-glucan  (WUM-BS) 
showed no significant effect on IL-8 secretion and proliferation of two intestinal epithelial 
cell  lines,  Caco-2  and  HT-29,  and  had  no  significant  effect  on  the  
NF-κB activity in the monocytic cell line U937-3κB-LUC. Further enriched arabinoxylan 
fractions (WUM-BS-LA) from different barley varieties (Tyra, NK96300, SB94897 and 
CDCGainer) were less active than the mixed-linked β-glucan rich fractions (WSM-TP and 
WSM-TPX) in the complement-fixing test. The mixed-linked β-glucan rich fraction from 
NK96300  and  CDCGainer  showed  similar  activities  as  the  positive  control  while 
mixed-linked β-glucan rich fractions from Tyra and SB94897 were less active. From these 
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results it is concluded that the isolated high molecular weight mixed-linked β-glucans and 
arabinoxylans  from  barley  show  low  immunological  responses  in  selected  in  vitro  test 
systems  and  thus  possible  anti-colon  cancer  effects  of  barley  dietary  fiber  cannot  be 
explained by our observations. 
Keywords: arabinoxylan; mixed-linked β-glucan; barley; Caco-2; complement-fixing test; 
dietary fiber; HT-29; IL-8; U937; NF-kappaB 
 
1. Introduction  
Dietary fiber have been claimed to protect against the development of colorectal cancer (CRC) [1], 
but according to several reviews, evidence of such a relationship is scarce [2–4]. CRC is one of the 
most common types of cancer world-wide, and also in Norway, the incidence of CRC has increased 
over  the  past  50  years.  The  reason  for  this  is  largely  unknown,  but  lifestyle  and  diet  probably 
contribute [5,6].  
Chronic inflammation is associated with increased risk of cancer development [7], and patients with 
inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease, have increased risk of 
developing CRCs [8]. Plasma levels of the acute phase protein C-Reactive Protein (CRP) which is a 
marker of inflammation, are elevated in persons who subsequently develop CRC [9]. Increased intake 
of dietary fiber reduces CRP levels [10–12] as well as the levels of the proinflammatory cytokines IL-6 
and TNF [13]. Strengthening the immune system’s ability to detect and eliminate cancer cells, a 
process called cancer immunosurveillance [14], on the other hand may have a protective effect. The 
potential of dietary fiber to promote cancer immunosurveillance is currently unknown. However barley 
beta-glucan has been shown to increase the effect of anti-tumor antibodies in mice [15,16]. In general, 
dietary  fiber  may  affect  inflammatory  processes  and  immune  responses  by  several  mechanisms. 
Amongst the most studied are the mechanisms exerted by butyrate, a short chain fatty acid produced in 
the colon following fermentation of dietary fiber. Butyrate has anti-inflammatory [17], apoptotic, and 
anti-proliferative activities on cancer cells [18,19]. Dietary fiber, depending on their structures, can 
affect  the  intestinal  immune  system  by  being  taken  up  by  M-cells  in  the  Peyer’s  patches  and 
transported to underlying immune cells and other cells. This may result in a local cytokine production 
which can influence T-cells, B-cells, antigen presenting cells and other immune cells. Fiber may also 
be taken up by intestinal macrophages or dendritic cells (i.e., antigen presenting cells) and transported 
to lymph nodes, spleen and bone marrow [20,21]. In addition, direct interaction of fiber with colonic 
epithelial cells or leukocytes may induce changes in immune reactions relevant for inflammation and 
the development of cancer.  
Barley (Hordeum vulgare) is an interesting source of dietary fiber and was previously the preferred 
grain for food in the Nordic region; mainly due to its short growing season due to the climate. In 
Norway, barley is still the major cereal crop, but only a part is used for human consumption, the 
majority is used as animal feed. Barley as well as oats are rich in dietary fiber, mainly mixed-linked  
β-glucans  and  arabinoxylans  [22,23].  In  these  cereals,  -glucans  are  linear  β-(13)/(14)-D-
glucopyranosyl polymers referred to as mixed- linked or cereal -glucans [24]. Int. J. Mol. Sci. 2011, 12                       
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Most of the previous studies on immunomodulatory activities of barley dietary fiber have focused 
on the mixed-linked β-glucans since they are structurally related to fungal and yeast β-glucans that are 
β-(13)-D-glucopyranosyl polymers with β-(16) linked side chains. In vitro and in vivo experiments 
on  β-glucan  preparations  from  yeast  and  fungi  have  shown  immunomodulating  properties  and  a 
potential to increase host resistance against infections [20]. Mixed-linked β-glucans from barley might 
have similar effects, although knowledge on immunomodulatory effects of barley polysaccharides is 
quite limited. Some activities have been reported on commercially available barley β-glucan; Intra 
peritoneal injections of barley -glucan into fish enhanced the leukocyte count, phagocytic activity, 
lysozyme activity, complement activity via the alternative pathway and serum bactericidal activity [25]. 
Czop  and  Austen  [26]  found  that  turbid  preparations  of  barley  -glucan  activate  the  alternative 
pathway of the complement system in vitro. In addition, pre-treatment of human monocytes with barley 
β-glucan  inhibited  phagocytosis  of  zymosan  particles  [26].  β-glucans  enhance  cytotoxicity  of 
phagocytes or NK cells towards iC3b-opsonized cells by binding to the lectin site on complement 
receptor 3 (CR3 or CD11b/CD18, Mac-1, M2 integrin) and thereby initiate cytotoxic degranulation 
of NK cells and phagocytosis by other cells [27–29]. Oral administered barley -glucan increased the 
efficacy of photodynamic therapy of Lewis lung carcinoma in mice through binding to CR3 [27], but 
barley β-glucan binds to CR3 with lower affinity than yeast β-glucan [29,30]. Barley -glucans also 
enhance the anti-tumor effect of monoclonal antibodies in mice when administered orally [16,31] by 
being  taken  up  by  gastrointestinal  macrophages,  transported to  the spleen, lymph  nodes  and bone 
marrow where smaller fragments of glucan are bound to CR3 on granulocytes which in turn kill iC3b-
opsonized tumor cells [15]. Barley -glucan can also bind to Dectin-1[32] and activate NF-κB when 
Dectin-1, Syk, CARD9 and Bcl10 are co-expressed in the cells [33]. The transcription factor NF-B 
plays a critical role in immune, cellular stress and inflammatory responses [34].  
Instead of using commercially available dietary fiber from barley in the present study we isolated 
fiber  fraction  from  barley,  both  mixed-linked  β-glucan  and  arabinoxylan  and  tested  for 
immunomodulatory activities related to inflammation. This involved extraction and the use of specific 
hydrolytic enzymes to isolate pure polysaccharide fractions and determination of biological activities 
by stimulation of the human colon epithelial cell lines Caco-2 and HT-29 followed by measurement of 
cell proliferation and cytokine secretion. In addition, we investigated the fiber`s ability to modulate 
NF-κB  activity  in  monocytes  and  their  influence  on  the  complement  system  using  the 
complement-fixing test [35], all systems involving factors with relevance to inflammatory processes. 
2. Results and Discussion 
2.1. Barley Dietary Fiber Fractions 
-glucan  and  arabinoxylan  samples  isolated  and  purified  from  the  common  Norwegian  barley 
variety Tyra were the main basis for our investigations. As shown in Table 1, the constituent sugar 
analysis combined with 
1H-NMR [23] (spectra not shown) revealed that WUM-BS contained 70% 
arabinoxylan and 30% mixed-linked -glucan. Treatment with lichenase (L) and amyloglucosidase (A) 
efficiently  removed  most  of  the  remaining  mixed-linked  -glucan  from  this  fraction;  the  enzyme 
treated  fraction  WUM-BS-LA  contained  96.4%  arabinoxylan.  Trace  amounts  of  mannose  were Int. J. Mol. Sci. 2011, 12                       
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attributed to the glycoprotein part of the enzyme preparation used. In this fraction, ferulic acid is not 
present due to alkali treatment during the extraction procedure. 
Table  1.  Characterization  of  fiber  fractions  from  Hordeum  vulgare  var.  Tyra: 
monosaccharide composition (mol %) and estimated molecular weight calculated on the 
basis of pullulan standards by GPC-SEC and refractive index detection, as weight average 
(Mw) and number average (Mn) of barley fiber fractions . 
  Monosaccharide Composition (mol%)  Molecular Weight (kDa) 
Fraction  Glc  Man  Xyl  Ara  Mw  Mn 
WSM-TP  91.0  0.0  5.8  3.3  1090  599 
WSM-TPX  96.5  0.0  1.9  1.6  886  501 
WUM-BS  30.0  0.0  52.7  17.3  412  98 
WUM-BS-LA  2.0  1.6  66.0  30.4  156  42 
 
WSM-TP  was  composed  of  90%  mixed-linked  -glucan  in  addition  to  10%  co-extracted 
arabinoxylan. Most of the arabinoxylan was removed by enzymatic treatment with xylanase (X). The 
enzyme treated fraction WSM-TPX was composed of 96.5% glucose and only 3.5% arabinoxylan.  
The estimated relative weight average molecular weights (Mw) based on the pullulan series were 
about 886 and 156 kDa for WSM-TPX and WUM-BS-LA, respectively (Table 1). Molecular weight 
decreased during the enzymatic treatment of WSM-TP and WUM-BS from about 1090 and 412 kDa, 
respectively, giving samples with less polydispersities (Mw/Mn). 
All previous studies on immunomodulatory activity of mixed-linked β-glucans from barley have been 
performed on commercially available samples. It should be noticed [20] that choice of isolation method 
may influence polysaccharide characteristics, such as molecular weight and solubility, and thereby their 
biological activities. In addition, co-extracted substances or contaminants of an endotoxin nature that may 
occur during isolation may contribute to significant activities in immunological test systems.  
Potential degradation of dietary fiber during food processing has not been taken into account in this 
study. In addition, the fact that dietary fiber very seldom is eaten alone without subsequent intake of 
several other food constituents makes the picture quite complex and complicated to explore. In the 
present study, all fiber fractions had relatively high molecular weight after isolation, and no attempts 
were made to alter the chain length in either of the samples. This was because we primarily wanted to 
investigate  intact  carbohydrate  dietary  fibers  with  the  presumption  that  dietary  fiber  remains 
undegraded until reaching the microflora in the colon.  
2.2. Effect on IL-8 Secretion and Cell Proliferation in Caco-2 and HT-29 
To test the inflammatory response of the fiber fractions on gut epithelial cells the modulation of  
IL-8 (CXCL8) secretion from the human intestinal epithelial cell lines Caco-2 and HT-29 cells was 
determined.  The  concentration  used  of  1  mg/mL  is  physiologically  relevant  as  a  concentration  of  
1 mg/mL barley fiber in the intestine corresponds to the consumption of approximately 20 g barley, an 
amount found, for example, in two slices of barley bread (40% barley flour). In addition, the potential 
toxic effect of the fiber fractions on the Caco-2 and HT-9 cells was determined by measuring the effect 
of the fiber fractions at different concentrations on cell proliferation using the MTT assay.  Int. J. Mol. Sci. 2011, 12                       
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We found that the fiber fractions had no significant effect on the cell proliferation of the human 
intestinal  epithelial  cell  lines  Caco-2  and  HT-29  cells  (Figure  1A,  B).  It  was  observed  that  the  
HT-29 cell line in general secretes considerably higher levels of IL-8 than Caco-2, but the barley fiber 
fractions had no significant effect on this secretion either from Caco-2 (Figure 2A) or HT-29 cells 
(Figure 2B). Only the positive controls, PMII and zymosan increased secretion of IL-8 from both cell 
lines significantly (p = 0.001) compared to the respective controls. Zymosan is a crude extract from 
yeast (Saccharomyces cerevisiae) and contains mainly -glucan but also some mannan [20], protein, 
fat and chitin [36]. Immunomodulatory activities of -glucan from yeast and from other sources have 
been studied extensively, for review on this topic see [37]. PMII is a pectic polysaccharide fraction 
isolated from Plantago major L. leaves, a plant used in traditional medicine to aid the healing of wounds. 
PMII has shown immunomodulatory activities both in vitro and in vivo: Increased resistance against 
bacterial  infection  in  mice,  activation  of  human  monocytes  and  activation  of  the  complement 
system [35,38,39]. PMII is therefore considered useful as positive control in immunological test systems.  
Even though we did not find any direct effect of the barley fiber fractions on the intestinal epithelial 
cell model system, barley fiber may affect inflammatory processes and immune response by other 
mechanisms. As outlined in the introduction, barley fiber may be taken up by intestinal macrophages or 
M-cells and delivered to underlying immune cells where binding of barley β-glucan to the lectin site of 
CR3 on effector cells has been shown to enhance cytotoxic activity [15,27].  
Figure  1.  The  effect  of  fiber  fractions  extracted  from  the  barley  variety  Tyra  on  cell 
proliferation of (A) Caco-2 cells and (B) HT-29 cells. Cells were incubated with three 
different concentrations of the respective fiber fraction in cell culture medium for 24 hours 
before  cell  proliferation  was  measured.  Each  bar  represents  the  mean  of  at  least  three 
experiments performed in triplicate (as % of medium control) ±  SD.  
 Int. J. Mol. Sci. 2011, 12                       
 
 
575 
Figure 1. Cont. 
 
Figure 2. IL-8 secretion from Caco-2 (A) and HT-29 (B) cells in response to treatment with 
fiber fractions extracted from the barley variety Tyra, zymosan and PMII (all 1 mg/mL). Cells 
were incubated with fiber of the respective fiber fractions in cell culture medium for 24 hours 
before  IL-8  secretion  was  measured.  Each  bar  represents  the  average  ±   SD  of  one 
representative experiment from a total of three independent experiments. * p < 0.05. 
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Figure 2. Cont. 
 
2.3. The Ability of the Fiber Fractions to Modulate NF-B Activity in Monocytes 
The nuclear transcription factor kappa B (NF-B) plays a central role in inflammatory response [40]. 
Thus, to further study the effect of the fiber fractions on the immune response, the ability of the fiber 
fractions to modulate basal and LPS-induced NF-B activity was tested using the U937-3B-LUC 
monocytic cell line stably transfected with a luciferase reporter containing three NF-B binding sites. It 
has been shown that this model system correlates well with in vivo NF-B activity [41,42] Due to the 
limitations of the test system, lower concentrations of the samples (0.1, 0.2 and 0.4 mg/mL) were used 
compared to experiments with the Caco-2 and HT-29 cell lines. However, as the U937-3B-LUC cell 
line is quite sensitive, the response is still considered relevant. The activities of the different fiber 
fractions were compared to the positive control, PMII [39]. Of the different fiber fractions only the 
highest  concentration  of  WUM-BS  had  a  significant  effect  on  basal  NF-B  activity  (p  =  0.004) 
(Figure 3A),  giving  an  increase  of  the  activity  to  270%  compared  to  control.  The  apparent  dose 
response from 0.1 mg/mL to 0.4 mg/mL of all fractions of the basal NF-B activity was statistically not 
significant compared to the control. However, all concentrations of PMII significantly increased basal 
NF-B activity (p < 0.001) in the test system compared to the control. None of the fiber fractions had 
significant effect on the LPS-induced NF-B activity, only the highest concentration of PMII increased 
the LPS-induced NF-B activity significantly (p = 0.013) (Figure 3B).  Int. J. Mol. Sci. 2011, 12                       
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Figure  3. The effect of the fiber fractions extracted from the barley variety Tyra on basal  
(A) and LPS-induced (B) NF-B activity. U937-3xκB-LUC cells were incubated with 0.1, 0.2 
or 0.4 mg/mL as indicated of the respective fiber fraction in cell culture medium for 6.5 hours 
before luciferase activity was measured. For LPS-induction, 1 g/mL LPS was added after 
30 min, and the cells incubated further for six hours before the luciferase activity was measured. 
Each  bar  represents  the  mean  of  at  least  three  experiments  performed  in  triplicate  ±  SD.  
* p < 0.05. 
 
 
 
Only  high  concentrations  of  a  fraction  containing  70%  arabinoxylan  and  30%  mixed-linked  
β-glucan  (WUM-BS)  increased  the  activity  of  the  pro-inflammatory  transcription  factor  NF-B  in 
A 
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monocytes. This fraction was obtained after alkaline extraction of a water insoluble residue. Neither 
pure arabinoxylan nor pure mixed-linked β-glucan was active in this test system. Some biological 
effects of β-glucans are initiated by binding to Dectin-1 on macrophages and dendritic cells. Barley  
β-glucan has previously been found to activate NF-B when Dectin-1, Syk, SARD9 and Bcl10 were 
co-expressed in the cells [33], and it was concluded that Dectin-1 was involved in these activities. 
However, binding to Dectin-1 requires β-glucans with a minimum of 10- or 11- mer 1,3-linked glucose 
oligomers [43] which are structural elements not found in barley. Barley β-glucans only contain single 
1,3-linked glucose units separating two or three 1,4-linked glucose oligomers [44]. Transcription factor 
NF-B  can  be  activated  via  many  different  pathways  including  proinflammatory  cytokines,  TLR 
activation, for example, by LPS and by T-cell activation [40]. As shown in Figure 3B, LPS induced 
NF-B activity was not significantly altered by any of the barley fractions indicating that the basal 
activity observed after stimulation of 0.4 mg/mL WUM-BS may be due to contamination by LPS. In 
any  case,  the  activity  found  in  Figure  3A  cannot  be  due  to  either  arabinoxylan  or  mixed-linked 
-glucan  since  other  fractions  containing  higher  levels  of  mixed-linked  -glucan  (WSM-TP  and 
WSM-TPX) and arabinoxylan (WUM-BS-LA) were inactive in the test system. The positive control 
PMII increased LPS induced activity but to a lesser extent than measured with PMII alone (Figure 3A). 
This shows that PMII is active per se, but confirms presence of LPS. Previously, it has been shown that 
PMII can activate monocytes and induce secretion of TNF [39]. One might speculate that secreted 
TNF in turn activate NF-B [40], alternatively PMII may bind to NF-B activating receptors directly. 
2.4. Complement Fixing Test 
Purified β-glucan (WSM-TPX) and arabinoxylan (WUM-BS-LA) from Tyra were tested for activity 
in  the  complement-fixing  test.  Both  showed  lower  activities  than  the  positive  control,  PMII.  At 
1 mg/mL WSM-TPX was significantly more active than WUM-BS-LA (p = 0.009) (Figure 4). 
β-glucans and purified arabinoxylans from other barley varieties [45] were also subjected to this 
test.  As  shown  in  Figure  4,  all  arabinoxylan  fractions  (WUM-BS-LA)  had  relatively  low  activity 
compared to the positive control. Arabinoxylan isolated from Tyra, NK96300 and SB94897 had very 
similar activities; the one from CDC Gainer was almost inactive.  
Starch-free mixed-linked -glucans that had not been subjected to a xylanase treatment (WSM-TP) 
containing additional small amounts of arabinoxylan, had the highest activity in this test system. Such 
WSM-TP samples originating from CDC Gainer and NK96300 showed activity at the same level as the 
positive control, while similar fractions from Tyra and SB94897 were less active (p < 0.035). Figure 4 
furthermore shows that a xylanase purification step of WSM-TP into purified mixed-linked -glucan 
(WSM-TPX) did not alter the complement-fixing activity significantly.  
In general, all mixed-linked β-glucan rich fractions had a significantly higher complement-fixing 
activity than the arabinoxylan-rich fractions (p < 0.027).  
According to Figure 4 the fractions can be listed as follows with regard to decreasing activity in the 
complement fixing test: PMII = WSM-TP CDC Gainer = WSM-TP NK96300 > WSM-TP Tyra = 
WSM TPX Tyra = WSM TP SB94897 > WUM BS-LA Tyra = WUM-BS-LA NK96300 = WUM-BS-
LA SB94897 > WUM-BS-LA CDC Gainer. 
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Figure 4. Complement fixing test of fiber fractions isolated from barley varieties. Each bar 
represents  %  activity  (mean  values  of  triplicates  ±   SD)  of  the  positive  control  PMII 
measured at 1 mg/mL. The fractions are arabinoxylan (WUM-BS-LA) and mixed-linked 
β-glucan  rich  fractions  (WSM-TP  and  WSM-TPX)  from  the  barley  varieties  Tyra, 
NK96300, SB94897 and CDC Gainer. Activity bars denoted with the same letter (a, b or c) 
are not significantly different, p < 0.05.  
 
Mixed-linked β-glucans from barley have previously shown to activate the complement system via 
the alternative pathway [26], the present study demonstrates an effect also on the classical pathway. 
The complement system provides a first line of protection against potential harmful invaders and is 
part of the innate immune system. It consists of a group of serum proteins that are activated in a 
cascade  mechanism.  Many  of  these  proteins  are  pro-enzymes  that  are  activated  by  proteolytical 
cleavage  which  in  turn  activate  the  next  step  in  the cascade. Activation can be initiated by three 
pathways; the classical pathway, the alternative pathway or the lectin pathway, and is important for 
initiating inflammation, activation of leucocytes, lysis of target cells and opsonisation [46,47]. The test 
system employed has some limitations since it does not distinguish between activation and inhibition 
of the complement cascade, only a ―consumption‖ of complement activity is registered. From previous 
studies however, it is established that PMII, the positive control, is an activator of the complement 
system [35], and it has also shown to protect against bacterial infection in vivo [38].  
The mixed-linked -glucan fractions tested were more active than the arabinoxylan fractions. The 
reason for the differences in activity of the different -glucans might be due to differences in their 
primary  structure.  The  ratio  of  (14)/(13)  linkages  present  varies  between  the  different  barley 
varieties tested. NK96300 has the highest ratio (2.76) followed by CDC Gainer (2.59), Tyra (2.48) and 
SB94897 (2.30) [23]. The varieties with the highest (14)/(13) ratio have the highest activity in the 
complement fixing test, but statistical analysis shows no significant correlation between linkage ratio 
and activity or between molecular weight of the WSM-TP fractions and activity. Mw of WSM-TP 
fractions from NK96300, CDC Gainer and SB94897 were estimated to 1040, 1130 and 1040 kDa, 
respectively. The estimated molecular weights of the WSM-TP fractions were significantly higher than 
the  corresponding  arabinoxylan  (WUM-BS-LA)  fractions  (p  <  0.001).  Mw  of  the  WUM-BS-LA Int. J. Mol. Sci. 2011, 12                       
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fractions  from  NK96300,  CDC  Gainer  and  SB94897  were  estimated  to  214,  203  and  190  kDa, 
respectively.  The  WUM-BS-LA fractions  from  different  barley varieties  tested had in general low 
activities in the complement fixing test. However, when both these arabinoxylan fractions and the more 
active -glucan rich fractions were included in the statistical test a significant positive correlation was 
found between molecular weight and activity (p = 0.002). On the other hand, when these two classes of 
dietary  fiber  are  evaluated  separately  there  is  no  correlation  between  activity  and  their  estimated 
molecular  weights.  Contamination  of  LPS  does  not  affect  this  test  system  [48], so  activity is  not 
attributed to presence of endotoxin. 
The  arabinoxylans  from  different  barley  varieties  tested  had  in  general  low  activities  in  the 
complement fixing test leaving this hemicellulose type of dietary fiber non-responsive in all the test 
systems in the present study. To our knowledge, high molecular weight arabinoxylans have not been 
ascribed immunomodulatory activities. On the other hand arabinoxylan oligosaccharides have been 
studied for prebiotic properties [49] and have been shown to reduce preneoplastic lesions in the colon 
of rats treated with a carcinogen [50].  
3. Experimental Section  
3.1. Isolation of Fiber Fractions 
Fiber  fractions  were  extracted  from  four  barley  varieties;  NK96300,  Tyra,  CDC  Gainer  and 
SB94897 basically as previously described [51]. Briefly; milled (0.5 mm) barley samples (48 g) were 
extracted and washed with boiling ethanol. This removed low molecular weight constituents and is 
promoting  the  denaturation  of  endogenous  hydrolytic  enzymes  such  as  β-glucanase.  Following 
defatting  with  hexane,  extraction  with  boiling  water  gave  a  water  soluble  material  (WSM)  and  a 
residue  of  water  insoluble  material  (WUM).  WSM  was  furthermore  treated  with  7  mL  amylase 
(Termamyl 120 L, Type L, Novozymes ) and 75 mg protease (Porcine Pancreatine, SIGMA) filtered 
and recovered with alcohol precipitation resulting in the starch free fraction designated WSM-TP.  
In an attempt to remove small amounts of co-extracted arabinoxylan, WSM-TP was treated with a 
xylanase. WSM-TP Tyra (1 g) was dissolved in sodium acetate buffer pH 4.5, and 10 µL (21 U) endo  
-xylanase (β-xylanase M6, Megazyme) was added at 40 ° C and left for 3 h with gentle stirring. 
Polysaccharide material was precipitated with isopropanol and centrifugated at 1000 ×  g for 10 min. 
The pellet was redissolved in water, dialyzed against distilled water using a dialyzing tube with cut off 
12,000–14,000 (Medicell Int. Ltd); freeze dried and designated WSM-TPX. 
Base soluble material (WUM-BS) was then extracted from the previous water insoluble residue 
(WUM) with 1 M NaOH added 1% NaBH4. Co-extracted mixed-linked -glucans and starch were 
removed by adding 50 U lichenase (Lichenase EC 3.2.1.73, Megazyme) and 400 µL amyloglucosidase 
(Amyloglucosidase for Total Dietary Fiber Assay EC 3.2.1.3, SIGMA) as described elsewhere [51] 
giving fractions designated WUM-BS-LA. Int. J. Mol. Sci. 2011, 12                       
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3.2. Monosaccharide Composition 
Methanolysis combined with TMS-derivatisation and GC were performed according to the method 
of  Chambers  &  Clamp  [52]  with  modifications  as  previously  described  [53]  using  4  M  HCl  in 
anhydrous methanol for 24 h at 80 ° C.  
3.3. 
1H-NMR  
1H-NMR  spectra  of  selected  samples  were  obtained  on  a  Varian  Mercury  300  system. 
Approximately 4 mg of freeze dried material was solubilized in 0.7 mL D2O, transferred to NMR glass 
tubes and acquired at 80 ° C with typically 64 scans. Further details of the method are described in 
Knutsen & Holtekjolen [23] . 
3.4. HPLC 
GPC-SEC was performed using a DIONEX P680 pump with a Spectraphysics AS3500 auto injector 
and a Shimadzu RID6A refractive index detector controlled with Chromeleon 6.80 software. Serially 
connected  Shodex  OHPack  SB-806-HQ  and  SB  804-HQ  columns  were  connected  to  a  Shodex 
OHPack SB-LG precolumn and eluted at 40 ° C with 50 mM Na2SO4 (0.5 mL/min), and samples  
(1 mg/mL) were injected using a 100 µL loop. Relative molecular weight averages (Mw and Mn) were 
estimated offline by the software WINGPC −6.2 using pullulan molecular weight standards ranging 
from  Mp  342  to  1,520,000  Da  for  calibration.  Software  and  standards  were  obtained  from  PSS 
(Polymer Standards Service GmbH, Mainz, Germany). 
3.5. Cell Cultures 
The Caco-2 cell line (obtained from the American Type Culture Collection (ATCC), and a generous 
gift from Professor Kirsten Sandvig, Norwegian Radium Hospital) and HT-29 cell line (obtained from 
ATCC, and a generous gift from Professor Tor Lea, Norwegian University of Life Sciences) were 
grown in DMEM medium containing 10% fetal calf serum, 1% non-essential amino acids, 100 U/mL 
penicillin,  and  100  mg/mL  streptomycin.  The  U937-3xkB-LUC  cell  line  (a  generous  gift  from 
Professor Rune Blomhoff, University of Oslo) was grown in RPMI-1640 medium supplemented with 
10%  fetal  bovine  serum,  2  mM  L-glutamine,  50  U/mL  penicillin,  50  mg/mL  streptomycin  and 
75 µg/mL hygromycin (Sigma-Aldrich, St. Louis, MO). The cells were maintained at 37 ° C and 5% 
CO2 in a humidified incubator. If not otherwise stated, all solutions were obtained from Invitrogen 
(Carlstad, CA).  
3.6. Measurement of Cell Proliferation and IL-8 Secretion 
For IL-8 secretion, cells were plated in 12-well plates. For cell proliferation, cells were plated in  
96-well  plates.  Cells  were  plated  at  a  concentration  of  1.0 ×  10
5  cells/mL  (Caco-2)  and 
1.5 ×  10
5 cells/mL  (HT-29)  and  incubated  until  they  reached  80  %  confluency  (48  h).  The  fiber 
fractions were solubilized in water by boiling for 20 min, aliquoted, freeze dried and re-solubilized in 
growth medium to treatment concentrations of 0.5–3 mg/mL. A yeast derived beta-glucan (Zymosan A Int. J. Mol. Sci. 2011, 12                       
 
 
582 
Z4250 Sigma) and PMII, a plant polysaccharide fraction from Plantago major L with known immune 
stimulating activity [35,38,39] were used as positive controls for IL-8 secretion. Cells were incubated 
24 h with 1.5 mL (12-well plates) or 100 µL (96-well plates) growth medium or solubilized fiber 
fractions in duplicate (12-well plates) or triplicate (96-well plates). At the end of the incubation, the 
plates were processed for measurement of either cell proliferation or IL-8 secretion. 
Cell proliferation was determined using the colorimetric MTT assay (Roche Diagnostics GmbH, 
Mannheim, Germany) that measures the ability of metabolic active cells to cleave tetrazolium sodium 
salt to purple formazan crystals [54]. The resulting purple precipitate in each cell was dissolved in 
100 μL isopropanol containing 0.04 M HCl, and the absorbance measured at 562 nm using Titertek 
Multiscan  plus  MK  II  plate  reader  (Labsystems,  Finland).  IL-8  concentrations  in  the  cell  culture 
supernatants were determined using an enzyme linked immunosorbent assay  (ELISA). Monoclonal 
mouse anti-human IL-8 antibody (BD Bioscience Pharmingen, San Diego, CA) suspended in coating 
buffer (0.1 M Carbonate/Bicarbonate buffer pH 9.6) was added to MaxiSorp
TM ELISA plates (Nunc, 
Roskilde,  Denmark)  and  incubated  over  night  at  4 ° C. Plates  were washed three times with  PBS 
containing 0.01% Tween-20 and unspecific binding-sites were blocked by incubating with 5% BSA in 
PBS for 1 h at room temperature. After washing five times with PBS-Tween, samples and human 
recombinant IL-8 standards (BD Bioscience Pharmingen,) diluted in working strength high performance 
ELISA (HPE) buffer from Sanquin (Amsterdam, Netherlands) were added to the plates, which were then 
incubated for 1.5 h at room temperature followed by washing five times with PBS-Tween. Plates were then 
incubated  for  1  h  with  biotinylated  mouse  anti-human  IL-8  monoclonal  antibody  (BD  Bioscience 
Pharmingen) in HPE buffer. After another washing step streptavidin-horseradishperoxidase conjugate (BD 
Bioscience Pharmingen) in HPE buffer was added and incubated at room temperature for 30 min. Plates 
were  then  washed  five  times  with  30  sec  between  each  wash.  Color  developed  after  addition  of 
3,3’,5,5’-tetramethylbenzidine (Sigma-Aldrich) in 0.05 M Phosphate-Citrate-Buffer containing H2O2. 
After 10 min the reaction was stopped by addition of 1 M H2SO4, and absorbance was measured at 
450 nm using the Titertek Multiscan plus MK II plate reader (Labsystems, Finland). The detection 
limit of the IL-8 ELISA was 2 pg/mL. 
3.7. NF-kB Activity Assay 
In  order  to  measure  NF-B  activity  the  U937-3xB-LUC  cell  line  were  transferred  to  RPMI 
medium with 2 % fetal bovine serum and seeded out in 96 well plates. The fiber fractions extracted 
from the barley variety Tyra were mixed with highly purified water (Milli-Q, 18.2 M to a final 
concentration of 1 mg/mL in Precellys CK14 homogenization tubes (Bertin Technologies, Montigny le 
Bretonneux, France), solubilized using the Precellys 24 homogenizer (Bertin Technologies) followed 
by boiling the samples for 5 min, and then freeze dried. The resulting freeze dried fiber fractions were 
dissolved in medium with 2% serum to a concentration of 4 mg/mL. PMII from Plantago major L. 
leaves was used as positive control [35,38,39]. This final solution of the fiber fractions was diluted 
directly in the wells giving the final concentrations of 0.1, 0.2 and 0.4 mg/mL. To measure basal NF-B 
activity,  cells  were  incubated  with  fiber  fractions  or  vehicle  control  for  6.5  hours.  To  measure 
lipopolysaccharide (LPS)-induced NF-κB activity, cells were pre-incubated with fiber fractions or vehicle 
control for 30 min, then 1 µg/mL lipopolysaccharide isolated from E. coli 0111:B4 (Sigma-Aldrich, St. Int. J. Mol. Sci. 2011, 12                       
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Louis, MO, U.S.) was added to the cells and the incubation continued for 6 hours. Cell viability for 
these  cells  was  determined  with  the  use  of  the  CellTiter-Glo  Luminiscent  Cell  Viability  Assay 
(Promega, Madison, WI, U.S.) with cut-off value of 10% non-viable cells. The NF-B activity was 
determined  by  measuring  the  luciferase  activity  after  addition  of  Bright-Glo
TM  Reagent  (Pomega, 
Madison, WI, U.S.) in accordance to the manufacturer’s instructions. Luminescence was detected for 1 
sec using the Glomax96 Microplate Luminometer (Promega, Madison, WI, U.S.).  
3.8. Complement Fixing Test 
Human complement proteins were incubated with fiber fractions that might either activate or inhibit 
activation  of  the  complement  proteins.  In  both  situations  complement  activity  is  depleted  with  a 
negative influence on a balanced hemolysis system involving antibody-sensitized sheep red blood cells 
and  a  human  serum  diluted  to  give  50%  hemolysis.  The  degree  of  hemolysis  was  measured  as 
absorbency at 405 nm. Fiber fractions were tested in triplicates using PMII, a polysaccharide fraction 
from Plantago major L. as positive control [35,39]. 
3.9. Statistics 
Analysis  of  significant  differences  was  tested  by  one-way  analysis  of  variance  (ANOVA)  with 
Dunnett’s  comparisons  with  a  control  and  Pearson  correlation  analysis using Minitab  Version 16. 
Differences were considered significant when p < 0.05. 
4. Conclusions  
From the experiments presented, it is concluded that purified high molecular weight mixed-linked 
β-glucans from barley have quite low immunological responses and do not affect proliferation and 
secretion of IL-8 of the colon epithelial cell lines Caco-2 and HT-29, or NF-kappaB activity in the 
monocytic  cell  line  U937-3B-LUC  but  are  active  in  the  complement-fixing  test.  High  molecular 
weight barley arabinoxylans have neglectible activities in all test systems mentioned. Taken together 
the results do not support that barley dietary fiber protect against the development of CRC through the 
immune responses or inflammatory responses tested. Still, one cannot overrule that such effects may 
occur through other mechanisms that may be shown in other test systems. 
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